HomeELTX • NASDAQ
add
Elicio Therapeutics Inc
Previous close
$4.92
Day range
$4.89 - $5.15
Year range
$3.34 - $11.45
Market cap
80.09M USD
Avg Volume
44.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.48M | 43.48% |
Net income | -14.00M | -56.49% |
Net profit margin | — | — |
Earnings per share | -1.02 | 73.02% |
EBITDA | -13.39M | -43.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.62M | 36.64% |
Total assets | 28.18M | 3.80% |
Total liabilities | 39.49M | 150.36% |
Total equity | -11.31M | — |
Shares outstanding | 15.94M | — |
Price to book | -4.78 | — |
Return on assets | -101.22% | — |
Return on capital | -309.20% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -14.00M | -56.49% |
Cash from operations | -8.74M | 11.63% |
Cash from investing | -45.00K | — |
Cash from financing | 227.00K | -96.76% |
Net change in cash | -8.54M | -194.92% |
Free cash flow | -3.81M | 28.31% |
About
Founded
2011
Headquarters
Website
Employees
32
